{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:33:04Z","timestamp":1789061584798,"version":"build-2803163510"},"reference-count":43,"publisher":"Tohoku University Medical Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1620\/tjem.2025.j009","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T17:12:18Z","timestamp":1738170738000},"page":"199-207","source":"Crossref","is-referenced-by-count":5,"title":["Effects of Liraglutide on Leptin Promoter Methylation in Ovarian Granulosa Cells of Obese Polycystic Ovary Syndrome Patients"],"prefix":"10.1620","volume":"266","author":[{"given":"Lina","family":"Su","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Shanxi Fenyang Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Shanxi Fenyang Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhong","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Shanxi Fenyang Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Abdulslam Abdullah, A., Ahmed, M., Oladokun, A., Ibrahim, N.A. &amp; Adam, S.N.(2022) Serum leptin level in Sudanese women with unexplained infertility and its relationship with some reproductive hormones. <i>World J. Biol. Chem.<\/i>, 13, 83-94.","DOI":"10.4331\/wjbc.v13.i5.83"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Barthelmess, E.K. &amp; Naz, R.K.(2014) Polycystic ovary syndrome: current status and future perspective. <i>Front. Biosci.<\/i> (<i>Elite Ed.<\/i>), 6, 104-119.","DOI":"10.2741\/E695"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bednarz, K., Kowalczyk, K., Cwynar, M., Czapla, D., Czarkowski, W., Kmita, D., Nowak, A. &amp; Madej, P.(2022) The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome. <i>Int. J. Mol. Sci.<\/i>, 23, 4334.","DOI":"10.3390\/ijms23084334"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Burt Solorzano, C.M., Beller, J.P., Abshire, M.Y., Collins, J.S., McCartney, C.R. &amp; Marshall, J.C.(2012) Neuroendocrine dysfunction in polycystic ovary syndrome. <i>Steroids<\/i>, 77, 332-337.","DOI":"10.1016\/j.steroids.2011.12.007"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Cao, J., Nie, G., Dai, Z., Shan, D. &amp; Wei, Z.(2023) Comparative effects of acupuncture and metformin on insulin sensitivity in overweight\/obese and lean women with polycystic ovary syndrome and insulin resistance: a post hoc analysis of a randomized trial. <i>Front. Med.<\/i> (<i>Lausanne<\/i>), 10, 1232127.","DOI":"10.3389\/fmed.2023.1232127"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Comim, F.V., Hardy, K. &amp; Franks, S.(2013) Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome. <i>PLoS One<\/i>, 8, e80416.","DOI":"10.1371\/journal.pone.0080416"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Cui, H., Lopez, M. &amp; Rahmouni, K.(2017) The cellular and molecular bases of leptin and ghrelin resistance in obesity. <i>Nat. Rev. Endocrinol.<\/i>, 13, 338-351.","DOI":"10.1038\/nrendo.2016.222"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Dean, J.P., Sprenger, C.C., Wan, J., Haugk, K., Ellis, W.J., Lin, D.W., Corman, J.M., Dalkin, B.L., Mostaghel, E., Nelson, P.S., Cohen, P., Montgomery, B. &amp; Plymate, S.R.(2013) Response of the insulin-like growth factor (IGF) system to IGF-IR inhibition and androgen deprivation in a neoadjuvant prostate cancer trial: effects of obesity and androgen deprivation. <i>J. Clin. Endocrinol. Metab.<\/i>, 98, E820-828.","DOI":"10.1210\/jc.2012-3856"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Escobar-Morreale, H.F. (2018) Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. <i>Nat. Rev. Endocrinol.<\/i>, 14, 270-284.","DOI":"10.1038\/nrendo.2018.24"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Faghfoori, Z., Fazelian, S., Shadnoush, M. &amp; Goodarzi, R.(2017) Nutritional management in women with polycystic ovary syndrome: A review study. <i>Diabetes Metab. Syndr.<\/i>, 11 Suppl 1, S429-S432.","DOI":"10.1016\/j.dsx.2017.03.030"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Friedman, J.M. (2009) Leptin at 14 y of age: an ongoing story. <i>Am. J. Clin. Nutr.<\/i>, 89, 973S-979S.","DOI":"10.3945\/ajcn.2008.26788B"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Frossing, S., Nylander, M., Chabanova, E., Frystyk, J., Holst, J.J., Kistorp, C., Skouby, S.O. &amp; Faber, J.(2018) Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial. <i>Diabetes Obes. Metab.<\/i>, 20, 215-218.","DOI":"10.1111\/dom.13053"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Ge, J.J., Wang, D.J., Song, W., Shen, S.M. &amp; Ge, W.H.(2022) The effectiveness and safety of liraglutide in treating overweight\/obese patients with polycystic ovary syndrome: a meta-analysis. <i>J. Endocrinol. Invest.<\/i>, 45, 261-273.","DOI":"10.1007\/s40618-021-01666-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Genchi, V.A., Rossi, E., Lauriola, C., D&apos;Oria, R., Palma, G., Borrelli, A., Caccioppoli, C., Giorgino, F. &amp; Cignarelli, A.(2022) Adipose Tissue Dysfunction and Obesity-Related Male Hypogonadism. <i>Int. J. Mol. Sci.<\/i>, 23, 8194.","DOI":"10.3390\/ijms23158194"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Jensterle, M., Kravos, N.A., Pfeifer, M., Kocjan, T. &amp; Janez, A.(2015) A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome. <i>Hormones<\/i> (<i>Athens<\/i>), 14, 81-90.","DOI":"10.1007\/BF03401383"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Kahal, H., Kilpatrick, E., Rigby, A., Coady, A. &amp; Atkin, S.(2019) The effects of treatment with liraglutide on quality of life and depression in young obese women with PCOS and controls. <i>Gynecol. Endocrinol.<\/i>, 35, 142-145.","DOI":"10.1080\/09513590.2018.1505848"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Kasa-Vubu, J.Z., Jain, V. &amp; Welch, K.(2010) Impact of fatness, insulin, and gynecological age on luteinizing hormone secretory dynamics in adolescent females. <i>Fertil. Steril.<\/i>, 94, 221-229.","DOI":"10.1016\/j.fertnstert.2009.02.072"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L. &amp; Azziz, R.(2016) Criteria, prevalence, and phenotypes of polycystic ovary syndrome. <i>Fertil. Steril.<\/i>, 106, 6-15.","DOI":"10.1016\/j.fertnstert.2016.05.003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Maheshwari, A., Stofberg, L. &amp; Bhattacharya, S.(2007) Effect of overweight and obesity on assisted reproductive technology--a systematic review. <i>Hum. Reprod. Update<\/i>, 13, 433-444.","DOI":"10.1093\/humupd\/dmm017"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Marchi, M., Lisi, S., Curcio, M., Barbuti, S., Piaggi, P., Ceccarini, G., Nannipieri, M., Anselmino, M., Di Salvo, C., Vitti, P., Pinchera, A., Santini, F. &amp; Maffei, M.(2011) Human leptin tissue distribution, but not weight loss-dependent change in expression, is associated with methylation of its promoter. <i>Epigenetics<\/i>, 6, 1198-1206.","DOI":"10.4161\/epi.6.10.16600"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Matsubara, H., Ikuta, K., Ozaki, Y., Suzuki, Y., Suzuki, N., Sato, T. &amp; Suzumori, K.(2000) Gonadotropins and cytokines affect luteal function through control of apoptosis in human luteinized granulosa cells. <i>J. Clin. Endocrinol. Metab.<\/i>, 85, 1620-1626.","DOI":"10.1210\/jcem.85.4.6509"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Meier, R.K. (2018) Polycystic Ovary Syndrome. <i>Nurs. Clin. North Am.<\/i>, 53, 407-420.","DOI":"10.1016\/j.cnur.2018.04.008"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Nylander, M., Frossing, S., Clausen, H.V., Kistorp, C., Faber, J. &amp; Skouby, S.O.(2017) Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial. <i>Reprod. Biomed. Online<\/i>, 35, 121-127.","DOI":"10.1016\/j.rbmo.2017.03.023"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Osinski, V., Bauknight, D.K., Dasa, S.S.K., Harms, M.J., Kroon, T., Marshall, M.A., Garmey, J.C., Nguyen, A.T., Hartman, J., Upadhye, A., Srikakulapu, P., Zhou, A., O\u2019Mahony, G., Klibanov, A.L., Kelly, K.A.,  et al. (2020) In vivo liposomal delivery of PPARalpha\/gamma dual agonist tesaglitazar in a model of obesity enriches macrophage targeting and limits liver and kidney drug effects. <i>Theranostics<\/i>, 10, 585-601.","DOI":"10.7150\/thno.36572"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Papaetis, G.S., Filippou, P.K., Constantinidou, K.G. &amp; Stylianou, C.S.(2020) Liraglutide: New Perspectives for the Treatment of Polycystic Ovary Syndrome. <i>Clin. Drug Investig.<\/i>, 40, 695-713.","DOI":"10.1007\/s40261-020-00942-2"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Peng, Y., Yang, H., Song, J., Feng, D., Na, Z., Jiang, H., Meng, Y., Shi, B. &amp; Li, D.(2022) Elevated Serum Leptin Levels as a Predictive Marker for Polycystic Ovary Syndrome. <i>Front. Endocrinol.<\/i> (<i>Lausanne<\/i>), 13, 845165.","DOI":"10.3389\/fendo.2022.845165"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Roth, L.W., Allshouse, A.A., Bradshaw-Pierce, E.L., Lesh, J., Chosich, J., Kohrt, W., Bradford, A.P., Polotsky, A.J. &amp; Santoro, N.(2014) Luteal phase dynamics of follicle-stimulating and luteinizing hormones in obese and normal weight women. <i>Clin. Endocrinol.<\/i> (<i>Oxf.<\/i>), 81, 418-425.","DOI":"10.1111\/cen.12441"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. <i>Fertil. Steril.<\/i>, 81, 19-25.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Salamun, V., Jensterle, M., Janez, A. &amp; Vrtacnik Bokal, E.(2018) Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study. <i>Eur. J. Endocrinol.<\/i>, 179, 1-11.","DOI":"10.1530\/EJE-18-0175"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Seth, M.K., Gulati, S., Gulati, S., Kumar, A., Rawat, D., Kumari, A., Sehgal, R., Zangmo, R., Dixit, V.,  Premlata &amp; Gulati, A. (2021) Association of Leptin with Polycystic Ovary Syndrome: a Systematic Review and Meta-Analysis. <i>J. Obstet. Gynaecol. India<\/i>, 71, 567-576.","DOI":"10.1007\/s13224-021-01510-0"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Siamashvili, M. &amp; Davis, S.N.(2021) Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome. <i>Expert Rev. Clin. Pharmacol.<\/i>, 14, 1081-1089.","DOI":"10.1080\/17512433.2021.1933433"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Singh, A., Fernandes, J.R.D., Chhabra, G., Krishna, A. &amp; Banerjee, A.(2019) Liraglutide modulates adipokine expression during adipogenesis, ameliorating obesity, and polycystic ovary syndrome in mice. <i>Endocrine<\/i>, 64, 349-366.","DOI":"10.1007\/s12020-019-01891-3"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Stubbs, S.A., Webber, L.J., Stark, J., Rice, S., Margara, R., Lavery, S., Trew, G.H., Hardy, K. &amp; Franks, S.(2013) Role of Insulin-like growth factors in initiation of follicle growth in normal and polycystic human ovaries. <i>J. Clin. Endocrinol. Metab.<\/i>, 98, 3298-3305.","DOI":"10.1210\/jc.2013-1378"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Tehrani, F.R., Simbar, M., Tohidi, M., Hosseinpanah, F. &amp; Azizi, F.(2011) The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. <i>Reprod. Biol. Endocrinol.<\/i>, 9, 39.","DOI":"10.1186\/1477-7827-9-39"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Umbayev, B., Saliev, T., Safarova Yantsen, Y., Yermekova, A., Olzhayev, F., Bulanin, D., Tsoy, A. &amp; Askarova, S.(2023) The Role of Cdc42 in the Insulin and Leptin Pathways Contributing to the Development of Age-Related Obesity. <i>Nutrients<\/i>, 15, 4964.","DOI":"10.3390\/nu15234964"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Wang, J., Gong, P., Li, C., Pan, M., Ding, Z., Ge, X., Zhu, W. &amp; Shi, B.(2020) Correlation between leptin and IFN-gamma involved in granulosa cell apoptosis in PCOS. <i>Gynecol. Endocrinol.<\/i>, 36, 1051-1056.","DOI":"10.1080\/09513590.2020.1760817"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Wang, M., Zhao, D., Xu, L., Guo, W., Nie, L., Lei, Y., Long, Y., Liu, M., Wang, Y., Zhang, X., Zhang, L., Li, H., Zhang, J., Yuan, D. &amp; Yue, L.(2019) Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome. <i>Metabolism<\/i>, 94, 47-58.","DOI":"10.1016\/j.metabol.2019.02.002"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Wei, J., Cheng, P., Kong, M., Zhang, L., Liu, S., Ning, B. &amp; Huang, X.(2023) MicroRNA-23a-3p overexpression represses proliferation and accelerates apoptosis of granular cells in polycystic ovarian syndrome by targeting HMGA2. <i>Gynecol. Endocrinol.<\/i>, 39, 2172155.","DOI":"10.1080\/09513590.2023.2172155"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Yang, J. &amp; Chen, C.(2024) Hormonal changes in PCOS. <i>J. Endocrinol.<\/i>, 261, e230342.","DOI":"10.1530\/JOE-23-0342"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Yokomori, N., Tawata, M. &amp; Onaya, T.(2002) DNA demethylation modulates mouse leptin promoter activity during the differentiation of 3T3-L1 cells. <i>Diabetologia<\/i>, 45, 140-148.","DOI":"10.1007\/s125-002-8255-4"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Zhao, S., Zhu, Y., Schultz, R.D., Li, N., He, Z., Zhang, Z., Caron, A., Zhu, Q., Sun, K., Xiong, W., Deng, H., Sun, J., Deng, Y., Kim, M., Lee, C.E.,  et al. (2019) Partial Leptin Reduction as an Insulin Sensitization and Weight Loss Strategy. <i>Cell Metab.<\/i>, 30, 706-719 e706.","DOI":"10.1016\/j.cmet.2019.08.005"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Zheng, J., Huang, S., Tong, Y., Wei, S., Chen, G., Huang, S. &amp; Ouyang, G.(2020) In-situ layer-by-layer synthesized TpPa-1 COF solid-phase microextraction fiber for detecting sex hormones in serum. <i>Anal. Chim. Acta.<\/i>, 1137, 28-36.","DOI":"10.1016\/j.aca.2020.08.047"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Zheng, S.H., Du, D.F. &amp; Li, X.L.(2017) Leptin Levels in Women With Polycystic Ovary Syndrome: A Systematic Review and a Meta-Analysis. <i>Reprod. Sci.<\/i>, 24, 656-670.","DOI":"10.1177\/1933719116670265"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/266\/3\/266_2025.J009\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:01:55Z","timestamp":1754107315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/266\/3\/266_2025.J009\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2025.j009","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2025.J009"}}